Yahoo
    NasdaqCM - Delayed Quote USD

    CytoMed Therapeutics Limited (GDTC)

    0.9188 +0.0182 (+2.02%)
    At close: October 30 at 4:00:00 PM EDT
    Loading Chart for GDTC
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

    CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
    GlobeNewswire 22d ago
    CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects

    CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects
    Simply Wall St. 8mo ago
    Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress

    Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
    TipRanks 8mo ago
    CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress

    CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
    GlobeNewswire 8mo ago
    CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

    CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
    GlobeNewswire 9mo ago
    CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia

    CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
    GlobeNewswire 10mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: